Sybx stock forecast.
According to the issued ratings of 2 analysts in the last year, the consensus rating for Synlogic stock is Buy based on the current 2 buy ratings for SYBX. The average twelve-month price prediction for Synlogic is $82.50 with a high price target of $90.00 and a low price target of $75.00. Learn more on SYBX's analyst rating history.
Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Panbela Therapeutics Inc have a median target of 20.50, with a high estimate of 25.00 and a low estimate of 16.00. The ...Synlogic Provides Corporate Update and Outlook for 2023 (GlobeNewswire) +11.33%. Jan-03-23 06:58AM Synlogic Announces Appointment of Dr. Dave Hava as Head of Research and Development ... (SYBX) a New Buy Stock (Zacks) Nov-30-21 10:54AM These 2 Penny Stocks Are Set for Massive Gains, Says Oppenheimer (TipRanks)CAMBRIDGE, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today summarized accomplishments for 2022 and outlined anticipated key milestones for …Nasdaq Futures 15874.25 -23.25 (-0.15%) Dow Jones Futures 34987.00 -32.00 (-0.09%) S&P 500 Futures 4523.75 0.50 (0.01%) EUR/USD 1.09 0.01 (0.57%) …29 sept. 2023 ... (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral ... stock (or common stock equivalents in lieu thereof) and (ii) ...
The average Mind Medicine stock price prediction forecasts a potential upside of 810.6% from the current MNMD share price of $3.02. What is MNMD's forecast return on equity (ROE) for 2023-2026? (NASDAQ: MNMD) forecast ROE is N/A, which is considered weak.2023-10-02 04:30 pm Chardan Genetic Medicines Conference - Fireside Chat 2023-09-21 09:00 am
Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.
Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Boxlight Corp have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate ...Following the reverse split, shares are trading at about $3.95 this morning. SYBX stock is down 5.6% as of Thursday morning, with some 2,000 shares changing hands. For the record, the company’s ...OPRA Stock 12 Months Forecast. $21.33. (84.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Opera in the last 3 months. The average price target is $21.33 with a high forecast of $23.00 and a low forecast of $19.00. The average price target represents a 84.20% change from the last price of $11.58.Nov 30, 2023 · View Synlogic, Inc SYBX investment & stock information. Get the latest Synlogic, Inc SYBX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Discover historical prices for SYBX stock on Yahoo Finance. View daily, weekly or monthly format back to when Synlogic, Inc. stock was issued.
Stock analysis for Synlogic Inc (SYBX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
CABA Stock 12 Months Forecast. Based on 8 Wall Street analysts offering 12 month price targets for Cabaletta Bio in the last 3 months. The average price target is $31.17 with a high forecast of $50.00 and a low forecast of $22.00. The average price target represents a 100.84% change from the last price of $15.52.Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Synlogic, Inc. (SYBX) : Free Stock Analysis Report. Amicus Therapeutics, Inc. (FOLD) : Free Stock ...May 13, 2023 · Synlogic ( NASDAQ:SYBX ) First Quarter 2023 Results Key Financial Results Net loss: US$15.6m (flat on 1Q 2022). US$0.23... The BigBear.ai Holdings Inc (NYSE: BBAI) stock price soared 318.8% after winning a 10-year $900 million IDIQ contract with the U.S. Air Force. The company is a leader in AI-powered analytics and cyber engineering solutions. YOUR CAPITAL IS AT RISK. 81% OF RETAIL CFD ACCOUNTS LOSE MONEY. The Indefinite …CABA Stock 12 Months Forecast. Based on 8 Wall Street analysts offering 12 month price targets for Cabaletta Bio in the last 3 months. The average price target is $31.17 with a high forecast of $50.00 and a low forecast of $22.00. The average price target represents a 100.84% change from the last price of $15.52.In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.
Wall Street expects a year-over-year decline in earnings on lower revenues when Synlogic, Inc. (SYBX Quick Quote SYBX - Free Report) reports results for the quarter ended March 2023.While this ...Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Panbela Therapeutics Inc have a median target of 20.50, with a high estimate of 25.00 and a low estimate of 16.00. The ... SYBX Stock Analysis Overview What this means: Synlogic Inc. (SYBX) gets an Overall Rank of 51, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.SYBX: Synlogic Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. BIOR Stock 12 Months Forecast. $50.00. (3603.70% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Biora Therapeutics in the last 3 months. The average price target is $50.00 with a high forecast of $50.00 and a low forecast of $50.00. The average price target represents a 3603.70% change from the last price of $1.35.22 nov. 2023 ... SYNLOGIC INC's (NASDAQ:SYBX) ... In today's session, TRACON PHARMACEUTICALS INC's (NASDAQ:TCON) stock price decreased by 12.81% to $0.19, ...Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 19.23% and 80.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
So consider, for a moment, the misfortune of Synlogic, Inc. (NASDAQ:SYBX) investors who have held the stock for three years as it declined a whopping 71%. That might cause some serious doubts ...
Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 19.23% and 80.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Nov 30, 2023 · View Synlogic, Inc SYBX investment & stock information. Get the latest Synlogic, Inc SYBX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. What is the current Price Target and Forecast for Synlogic (SYBX) Synlogic (SYBX) (Delayed Data from NSDQ) $1.99 USD -0.11 (-5.24%) Updated Nov 16, 2023 03:59 PM ET After-Market: $1.96 -0.03...The average Solid Power stock price prediction forecasts a potential upside of 136.38% from the current SLDP share price of $1.41. What is SLDP's forecast return on ... Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Panbela Therapeutics Inc have a median target of 20.50, with a high estimate of 25.00 and a low estimate of 16.00. The ... Find real-time CNVS - Cineverse Corp stock quotes, company profile, news and forecasts from CNN Business.According to the issued ratings of 2 analysts in the last year, the consensus rating for Synlogic stock is Buy based on the current 2 buy ratings for SYBX. The average twelve-month price prediction for Synlogic is $82.50 with a high price target of $90.00 and a low price target of $75.00. Learn more on SYBX's analyst rating history.
Synlogic, Inc. (SYBX) stock forecast and price target. Find the latest Synlogic, Inc. SYBX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
BigBear.ai Holdings, Inc. (NYSE:BBAI) released its quarterly earnings data on Tuesday, November, 7th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.10. The firm had revenue of $33.99 million for the quarter, compared to analyst estimates of $41.74 million.
Stock Price & Overview. Follow 10.55K followers. $0.480.01 (+2.13%)4:00 PM 12/01/23 ... SYBX · MYNZ · LUMO · ELEV. Company name. Synlogic, Inc. Mainz Biomed N.V..The BigBear.ai Holdings Inc (NYSE: BBAI) stock price soared 318.8% after winning a 10-year $900 million IDIQ contract with the U.S. Air Force. The company is a leader in AI-powered analytics and cyber engineering solutions. YOUR CAPITAL IS AT RISK. 81% OF RETAIL CFD ACCOUNTS LOSE MONEY. The Indefinite …Valuation metrics show that Synlogic, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of SYBX ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Solid Power Inc () Stock Market info Recommendations: Buy or sell Solid Power stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Solid Power share forecasts, stock quote and buy / sell signals below.According to present data Solid Power's SLDPW shares and potentially its market environment have been in …Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.BBAI Stock 12 Months Forecast. $3.50. (99.43% Upside) Based on 4 Wall Street analysts offering 12 month price targets for BigBearai Holdings in the last 3 months. The average price target is $3.50 with a high forecast of $4.50 and a low forecast of $2.00. The average price target represents a 99.43% change from the last price of $1.76. Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Cineverse Corp have a median target of 7.75, with a high estimate of 9.00 and a low estimate of 6.50. The median estimate ...
The BigBear.ai Holdings Inc (NYSE: BBAI) stock price soared 318.8% after winning a 10-year $900 million IDIQ contract with the U.S. Air Force. The company is a leader in AI-powered analytics and cyber engineering solutions. YOUR CAPITAL IS AT RISK. 81% OF RETAIL CFD ACCOUNTS LOSE MONEY. The Indefinite Delivery/Indefinite Quantity (IDIQ ...Personal Finance Crypto Sectors Contact Us U.S. markets close in 2 hours 47 minutes +271.84 (+0.49%) +48.57(+2.68%) (+0.45%) Gold (+1.47%) Synlogic, Inc. (SYBX) …According to . 2 Wall Street analysts that have issued a 1 year SYBX price target, the average SYBX price target is $82.50, with the highest SYBX stock price forecast at $90.00 and the lowest SYBX stock price forecast at $75.00.Instagram:https://instagram. nyse fceltoro company stocksteam powered carsqyld yield 5 jan. 2023 ... Stock Information · Stock Quote & Chart · Analyst Coverage · Corporate ... (Nasdaq: SYBX), a clinical-stage biotechnology company developing ... future trading vs forexstock market forecast tomorrow SYBX Stock Forecast. SYBX Stock Forecast - Is SYBX a buy or sell? Find out now with a free analysis on Synlogic. Should I buy or sell SYBX? SYBX Stock Analysis - [Full Report] SYBX Chart by TradingView. Atm Stocks Biopharma Stocks Biopharmaceutical Stocks Biotechnology Stocks Cancer Stocks Clinic Stocks Clinical Stocks ninjatrader futures options SYBX Stock Predictions, Articles, and Synlogic Inc News From InvestorPlace From the Web 3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year By Alex Sirois, InvestorPlace ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ... 29 sept. 2023 ... (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral ... stock (or common stock equivalents in lieu thereof) and (ii) ...